Esperion Therapeutics, Inc. (ESPR)
2.17
+0.12
(+5.85%)
USD |
NASDAQ |
Apr 15, 16:00
2.18
+0.01
(+0.46%)
After-Hours: 20:00
Esperion Therapeutics Research and Development Expense (Annual) : 47.85M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 117.07M |
| Harrow, Inc. | 12.85M |
| Corcept Therapeutics, Inc. | 254.91M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |